Sunhapas Soodvilai Selected Research

Sunhapas Soodvilai Research Topics

Disease

9	Polycystic Kidney Diseases (Polycystic Kidney Disease) 04/2022 - 01/2012
8	Cysts 04/2022 - 01/2013
7	Neoplasms (Cancer) 11/2021 - 01/2016
5	Inflammation (Inflammations) 11/2020 - 03/2012
4	Cholera 09/2014 - 01/2012
3	Autosomal Dominant Polycystic Kidney (ADPKD) 04/2022 - 01/2018
3	Body Weight (Weight, Body) 04/2022 - 01/2021
3	Type 2 Diabetes Mellitus (MODY) 08/2016 - 01/2008
2	Gram-Negative Bacterial Infections 04/2022 - 08/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2022 - 11/2021
2	Hepatocellular Carcinoma (Hepatoma) 02/2021 - 06/2020
2	Necrosis 10/2019 - 08/2015
1	Disease Progression 04/2022
1	Hemorrhage 04/2022
1	Obesity 02/2021
1	Insulin Resistance 02/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2020
1	Kidney Diseases (Kidney Disease) 11/2020
1	Astrocytoma (Pilocytic Astrocytoma) 05/2017
1	Glioma (Gliomas) 05/2017
1	Gliosis 05/2017
1	Learning Disabilities (Learning Disability) 05/2017
1	Memory Disorders (Memory Loss) 05/2017
1	Brain Neoplasms (Brain Tumor) 05/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2017
1	Ulcer 01/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015
1	Diarrhea 09/2014
1	Colitis 07/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2012
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Reperfusion Injury 10/2008
1	Ischemia 10/2008

Drug/Important Bio-Agent (IBA)

4	panduratin AIBA 04/2022 - 01/2021
4	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 04/2022 - 01/2012
4	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2016
4	Pharmaceutical PreparationsIBA 11/2020 - 01/2013
3	ChloridesIBA 04/2022 - 02/2014
3	Chalcone (Benzalacetophenone)IBA 11/2021 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 03/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 08/2021
2	AntioxidantsIBA 02/2021 - 01/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 02/2021 - 01/2015
2	ChitosanIBA 11/2020 - 07/2012
2	OligosaccharidesIBA 11/2020 - 07/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2018 - 01/2013
2	steviolIBA 05/2018 - 01/2013
2	steviosideIBA 05/2018 - 03/2012
2	LigandsIBA 01/2018 - 08/2013
2	Interleukin-6 (Interleukin 6)IBA 05/2017 - 08/2016
2	Cadmium Chloride (Cadmium Dichloride)IBA 05/2017 - 08/2015
2	isoliquiritigenin (GU 17)IBA 01/2012 - 01/2012
1	Peptides (Polypeptides)IBA 04/2022
1	Colistin (Coly-Mycin)FDA Link 04/2022
1	pinostrobinIBA 04/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	Caspase 3 (Caspase-3)IBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 02/2021
1	Metformin (Glucophage)FDA LinkGeneric 02/2021
1	CreatinineIBA 01/2021
1	Biological ProductsIBA 11/2020
1	PolymersIBA 11/2020
1	CationsIBA 06/2020
1	Messenger RNA (mRNA)IBA 06/2020
1	germacroneIBA 01/2020
1	Aquaporin 2IBA 05/2018
1	Vasopressins (Vasopressin)IBA 05/2018
1	Liver X ReceptorsIBA 01/2018
1	Lansoprazole (Prevacid)FDA LinkGeneric 01/2018
1	CadmiumIBA 05/2017
1	Interleukin-8 (Interleukin 8)IBA 05/2017
1	Fenofibrate (CiL)FDA LinkGeneric 01/2016
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2015
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	Diclofenac (SR 38)FDA LinkGeneric 09/2014
1	Cyclic AMP (AMP, Cyclic)IBA 09/2014
1	montelukast (Singulair)FDA Link 02/2014
1	zafirlukast (Accolate)FDA LinkGeneric 02/2014
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 02/2014
1	AMP-Activated Protein KinasesIBA 02/2014
1	pranlukastIBA 02/2014
1	CollagenIBA 08/2013
1	ColforsinIBA 08/2013
1	Chloride Channels (Chloride Channel)IBA 01/2013
1	AntidiarrhealsIBA 09/2012
1	Acetic Acid (Vinegar)FDA LinkGeneric 07/2012
1	Dextran SulfateIBA 07/2012
1	PPAR alphaIBA 01/2012
1	Fibric Acids (Fibrates)IBA 01/2012
1	Oleic Acid (Oleate)IBA 10/2008
1	CXA-10IBA 10/2008
1	Ethanol (Ethyl Alcohol)IBA 10/2008

Therapy/Procedure

5	Therapeutics 11/2020 - 01/2012
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
2	Oral Administration 04/2022 - 07/2012
1	Endurance Training 08/2016
1	Rectal Administration 07/2012
1	Injections 10/2008